(Q58614834)
Statements
Phase I clinical and pharmacokinetic study of kahalalide F administered weekly as a 1-hour infusion to patients with advanced solid tumors (English)
Beatriz Pardo
Luis Paz-Ares
Margarita García
Ramón Salazar
Ana López
María Blanco
Antonio Nieto
José Jimeno
Miguel Angel Izquierdo
José Manuel Trigo